Hepatitis C - Related CPT / HCPCS Codes
Code | Description |
---|---|
3218F | RNA testing for Hepatitis C documented as performed within 6 months prior to initiation of antiviral treatment for Hepatitis C (HEP-C) |
3220F | Hepatitis C quantitative RNA testing documented as performed at 12 weeks from initiation of antiviral treatment (HEP-C) |
3265F | Ribonucleic acid (RNA) testing for Hepatitis C viremia ordered or results documented (HEP C) |
3266F | Hepatitis C, genotype test |
3266F | Hepatitis C genotype testing documented as performed prior to initiation of antiviral treatment for Hepatitis C (HEP C) |
3514F | Hepatitis C screening documented as performed (HIV) |
4150F | Patient receiving antiviral treatment for Hepatitis C (HEP-C) |
36415 | Collection of venous blood by venipuncture |
81596 | Infectious disease, chronic hepatitis C virus (HCV) infection, six biochemical assays (ALT, A2-macroglobulin, apolipoprotein A-1, total bilirubin, GGT, and haptoglobin) utilizing serum, prognostic algorithm reported as scores for fibrosis and necroinflammatory activity in liver |
86038 | Anti-Nuclear Antibodies (ANA), IgG by ELISAÂ |
86803 | Hepatitis C antibody |
86804 | Hepatitis C antibody, confirmatory test |
87520 | Hepatitis C, direct probe technique |
87521 | Hepatitis C, amplified probe technique |
87522 | Hepatitis C, quantification |
87902 | Hepatitis C virus (HCV) genotype test |
87902 | Infectious agent genotype analysis by nucleic acid (DNA or RNA); Hepatitis C virus |
1014274 | Hepatitis C antibody |
G0472 | Hepatitis C antibody screening, for an individual at high risk and other covered indication(s) (This HCPCS code is used for patients covered by Medicare and other payers following Medicare guidelines) |
Â
Dear Confluence Users, If you need support for use of Atlassian tools, please contact informatics@nachc.com whether you have technical issues, need feature assistance, or simply have questions.